Language:
Currency:
1 ITEMS - $119.69 Bonus: 2
Your cart

Eflornithine Eflornithine 13.9 % x 2 tubes
Update 2 tubes to 3 tubes and save $ 53.97
$ 119.69 $ 119.69
Shipping method:
Delivery Insurance:
(Free reshipment if delivery fails)
  $ 5.50  
Pay at our secure server: $ 135.19  
Our discount gifts for all reliable consumers:
10% discount for all next orders 10% discount for all next orders
Free standard airmail service for all orders with sum starting at $200 Free standard airmail service for all orders with sum starting at $200
Free trackable courier service for all orders with sum starting at $300 Free trackable courier service for all orders with sum starting at $300


Testimonials
Sauro Manganelli, Follo, Italy
I’m pleased to tell you that I got my order today. Great website and service, I am happy with delivery on time. Fast, professional and polite! Highly recommend!
Elliot, 53, Tennessee
“I just turned 53 young, not so old, huh, and have been suffering from erectile dysfunction for more than 8 years. Different techniques and medications did not help me or were useful just for a while and then the problem returned. Only with Cialis I could ...
Neil, 46, Amsterdam
“This is my second time that I used Levitra. It is ok medication able to solve my erection problems. It worked me up as with other similar drugs I was lost.”
Read more...

Shipping Option

Secure Payment Process
News
'Don't be too kind': Maternity staff used offensive terms to refer to patients
BBC Panorama has seen documents and spoken to former midwives from Nottingham University Hospitals NHS Trust.
Daily pill doubles survival time for pancreatic cancer patients
The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.
Checks reveal young women with deadly 'silent' heart risk
Sudden cardiac death can happen without warning, and it's not just a problem for sporty young men, say experts.
Millions of breast cancer patients could safely avoid chemotherapy, study suggests
A new DNA test could help screen whether patients require the treatment or not, according to a new international trial.